• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, March 1, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS

Wide support in UK for novel DNA ‘transplants’ in human egg cells

Bioengineer by Bioengineer
March 21, 2013
in NEWS
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
 
The Human Fertilisation and Embryology Authority (HFEA) today voted to advise the government on the regulation of the techniques, which are meant to prevent the inheritance of mitochondria — which carry DNA outside the ordinary chromosomes in the nucleus — from mothers whose nuclear DNA is healthy. The procedures involve transferring the nucleus of an egg cell with diseased mitochondria to a healthy donor cell. 
 
The HFEA decision follows a public consultation on the science and ethics of the procedures, which was launched last September. The government must next decide whether to write legislation to legalize the procedures. Parliament would then need to pass the law. The HFEA would likely get the final say before the first procedures go forward. No other country has legalized the procedures, which combine in vitro fertilization with the egg cell swaps.
 
“We’ve done our work, now the work of the government begins,” said HFEA chair Lisa Jardine after a meeting to consider the public consultation in which no HFEA members raised significant objections to moving ahead. Their consultation involved public meetings, focus groups, questionnaires and other outreach. It found broad public support for allowing the procedures, when used to prevent serious diseases.
 
Approximately one in 5,000 women carry mutations in their mitochondria that put their children at risk of inheriting mitochondrial diseases, including forms of muscular dystrophy and diabetes. The two techniques being investigated — maternal spindle transfer (MST) and pronuclear transfer (PNT) — have been tested in animals, including mice and macaques, and in human cells.
 
A scientific review conducted as part of the consultation found no evidence to suggest that the techniques would be unsafe in humans. The review recommended additional experiments, including work underway to test PNT in healthy human egg cells (those experiments for MST were published last year1). The review also called for experiments to study the possibility that a small number of a mother’s faulty mitochondria could be carried over during the transfer and then become replicated enough during development to cause disease.
 
The HFEA’s recommendations to the government begin to spell out how the procedures would be regulated. HFEA wants the authority to license the clinics that perform the procedures and, initially at least, the ability to approve each use. Based on the public consultation, HFEA recommended that the donor and the child conceived through the procedures would receive only limited information about the other, and not their identities. Jardine estimated that only a handful of women would be candidates for the procedures and emphasised that the first trials are still likely to be years away.
 
"I have a small number of patients for whom this technique is applicable, and for whom this is a real opportunity to have a genetically related child without a devastating disease," says Shamima Rahman, a paediatrician and scientist at University College London's Institute of Child Health who treats patients with mitochondrial diseases. But more research into the safety and effectiveness of the procedures is necessary before trying them on patients.
 
Rachel Kean, a 24-year-old from London who has been diagnosed with a condition called mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, hailed the decision. “This is incredibly positive and something to be celebrated,” she says.

Story source:

The above story is reprinted from materials provided by Nature News.

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Microplastic sizes in Hudson-Raritan Estuary and coastal ocean revealed

March 1, 2021
IMAGE

Cancer: a new killer lymphocyte enters the ring

March 1, 2021

Single cell sequencing opens new avenues for eradicating leukemia at its source

March 1, 2021

Boston College physicist Brian Zhou receives NSF CAREER Award

March 1, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    648 shares
    Share 259 Tweet 162
  • People living with HIV face premature heart disease and barriers to care

    82 shares
    Share 33 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsBiologyPublic HealthEcology/EnvironmentcancerCell BiologyGeneticsTechnology/Engineering/Computer ScienceMedicine/HealthInfectious/Emerging DiseasesClimate ChangeChemistry/Physics/Materials Sciences

Recent Posts

  • Microplastic sizes in Hudson-Raritan Estuary and coastal ocean revealed
  • Cancer: a new killer lymphocyte enters the ring
  • Single cell sequencing opens new avenues for eradicating leukemia at its source
  • Boston College physicist Brian Zhou receives NSF CAREER Award
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In